Ki-67 (protein)

From WikiMD's Wellness Encyclopedia

Ki-67

High Ki-67 expression in an invasive Counting positive versus negative nuclei with Ki-67 labeling, in this case in a neuroendocrine tumor of the small intestine. To count as positive, a nucleus should be at least half within the field of view, be large enough, and not be located in the stroma. Otherwise, even weakly positive nuclei count as positive. Immunofluorescent antibody staining against neurofilament (green) and Ki-67 (red) in a mouse embryo 12.5 days after fertilization. The proliferating cells are in the ventricular zone in the Ki-67 is a protein that in humans is encoded by the MKI67 gene. It is a cellular marker for proliferation, and it is used extensively in research and diagnostic pathology to assess the growth fraction of cells in human tumors, which can be correlated with the clinical course of cancer. The Ki-67 protein is present during all active phases of the cell cycle (G1, S, G2, and mitosis), but is absent in resting cells (G0), making it an excellent marker for determining the fraction of proliferating cells in a given population of cells.

Function[edit | edit source]

Ki-67 is a nuclear protein that is associated with and may be necessary for cellular proliferation. Furthermore, Ki-67 expression is correlated with cell division, being highest in the G2 and M phases of the cell cycle, while the protein is not detected in quiescent cells (G0 phase). The exact function of Ki-67 is not fully understood, but it is thought to play a critical role in maintaining cell proliferation.

Clinical Significance[edit | edit source]

In oncology and histopathology, Ki-67 is a widely used marker to assess the growth fraction of cells in tumors. A high Ki-67 index (the percentage of Ki-67-positive cells among the total number of tumor cells observed) is often associated with aggressive tumors, which have a higher probability of growth and metastasis. Assessing the Ki-67 index can help in the prognosis and treatment planning for cancer patients, as it provides information on the aggressiveness of the tumor.

Immunohistochemistry[edit | edit source]

The detection of Ki-67 protein expression is commonly performed using immunohistochemistry on tissue sections. This technique involves the use of specific antibodies that bind to the Ki-67 protein, which can then be visualized using various detection systems, allowing pathologists to determine the proportion of cells that are actively proliferating within a tumor.

Limitations and Considerations[edit | edit source]

While Ki-67 is a valuable tool in the assessment of tumor proliferation, there are some limitations and considerations to keep in mind. The interpretation of Ki-67 staining can be subjective, and there is variability in the assessment of the Ki-67 index due to differences in staining techniques, the selection of the area of the tumor to be evaluated, and the cutoff values for high and low Ki-67 expression. Therefore, the Ki-67 index should be interpreted in the context of other clinical and pathological findings.

Research Applications[edit | edit source]

Beyond its clinical applications, Ki-67 is also used in basic and translational cancer research to study cell proliferation and the effects of various treatments on tumor growth. It serves as a crucial marker in studies aiming to understand the mechanisms of cancer progression and in the development of new therapeutic strategies.


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD